Widthness LLC

Advanced Business and Technology – Intel® Xeon® and A.I. Powered

Stroke Therapy Candidate 3K3A-APC Holds Promise for Dementia

1 min read
Stroke Therapy Candidate 3K3A-APC Holds Promise for Dementia

Article by Marisa Wexler MS. Alzheimer’s News Today – January 24, 2022.

3K3A-APC, an investigational therapy for stroke about to enter Phase 3 clinical testing, may also help to protect the brain against Alzheimer’s disease and other forms of dementia. “Our recent and current data support development of 3K3A-APC for neurological conditions associated with cognitive dysfunction such as Alzheimer’s disease and injury to the brain’s white matter that results in vascular dementia,” […]

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.